These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 29079708)

  • 1. miR-20a Regulates FAS Expression in Osteosarcoma Cells by Modulating
    Yang Y; Huang G; Zhou Z; Fewell JG; Kleinerman ES
    Mol Cancer Ther; 2018 Jan; 17(1):130-139. PubMed ID: 29079708
    [TBL] [Abstract][Full Text] [Related]  

  • 2. miR-20a encoded by the miR-17-92 cluster increases the metastatic potential of osteosarcoma cells by regulating Fas expression.
    Huang G; Nishimoto K; Zhou Z; Hughes D; Kleinerman ES
    Cancer Res; 2012 Feb; 72(4):908-16. PubMed ID: 22186140
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Fas/FasL Signaling Pathway: Its Role in the Metastatic Process and as a Target for Treating Osteosarcoma Lung Metastases.
    Koshkina N; Yang Y; Kleinerman ES
    Adv Exp Med Biol; 2020; 1258():177-187. PubMed ID: 32767242
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Participation of the Fas/FasL signaling pathway and the lung microenvironment in the development of osteosarcoma lung metastases.
    Huang G; Nishimoto K; Yang Y; Kleinerman ES
    Adv Exp Med Biol; 2014; 804():203-17. PubMed ID: 24924176
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The histone deacetylase inhibitor, MS-275 (entinostat), downregulates c-FLIP, sensitizes osteosarcoma cells to FasL, and induces the regression of osteosarcoma lung metastases.
    Rao-Bindal K; Koshkina NV; Stewart J; Kleinerman ES
    Curr Cancer Drug Targets; 2013 May; 13(4):411-22. PubMed ID: 23410027
    [TBL] [Abstract][Full Text] [Related]  

  • 6. VEGF165 is necessary to the metastatic potential of Fas(-) osteosarcoma cells but will not rescue the Fas(+) cells.
    Jia SF; Guan H; Duan X; Kleinerman ES
    J Exp Ther Oncol; 2008; 7(2):89-97. PubMed ID: 18771083
    [TBL] [Abstract][Full Text] [Related]  

  • 7. miR-214 promotes the proliferation and invasion of osteosarcoma cells through direct suppression of LZTS1.
    Xu Z; Wang T
    Biochem Biophys Res Commun; 2014 Jun; 449(2):190-5. PubMed ID: 24802407
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MicroRNA-26b inhibits metastasis of osteosarcoma via targeting CTGF and Smad1.
    Duan G; Ren C; Zhang Y; Feng S
    Tumour Biol; 2015 Aug; 36(8):6201-9. PubMed ID: 25761878
    [TBL] [Abstract][Full Text] [Related]  

  • 9. miRNA-20a upregulates TAK1 and increases proliferation in osteosarcoma cells.
    Yuan G; Zhao Y; Wu D; Gao C; Jiao Z
    Future Oncol; 2018 Feb; 14(5):461-469. PubMed ID: 29327611
    [TBL] [Abstract][Full Text] [Related]  

  • 10. P65-mediated miR-590 inhibition modulates the chemoresistance of osteosarcoma to doxorubicin through targeting wild-type p53-induced phosphatase 1.
    Long X; Lin XJ
    J Cell Biochem; 2019 Apr; 120(4):5652-5665. PubMed ID: 30387173
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MiR-20a triggers metastasis of gallbladder carcinoma.
    Chang Y; Liu C; Yang J; Liu G; Feng F; Tang J; Hu L; Li L; Jiang F; Chen C; Wang R; Yang Y; Jiang X; Wu M; Chen L; Wang H
    J Hepatol; 2013 Sep; 59(3):518-27. PubMed ID: 23665284
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of the histone deacetylase inhibitor SNDX-275 on Fas signaling in osteosarcoma cells and the feasibility of its topical application for the treatment of osteosarcoma lung metastases.
    Koshkina NV; Rao-Bindal K; Kleinerman ES
    Cancer; 2011 Aug; 117(15):3457-67. PubMed ID: 21287529
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MicroRNA-145 inhibits tumour growth and metastasis in osteosarcoma by targeting cyclin-dependent kinase, CDK6.
    Li Y; Liu J; Liu ZZ; Wei WB
    Eur Rev Med Pharmacol Sci; 2016 Dec; 20(24):5117-5125. PubMed ID: 28051259
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Effects of miR-20a on p21: Two Mechanisms Blocking Growth Arrest in TGF-β-Responsive Colon Carcinoma.
    Sokolova V; Fiorino A; Zoni E; Crippa E; Reid JF; Gariboldi M; Pierotti MA
    J Cell Physiol; 2015 Dec; 230(12):3105-14. PubMed ID: 26012475
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Upregulation of miR-328 and inhibition of CREB-DNA-binding activity are critical for resveratrol-mediated suppression of matrix metalloproteinase-2 and subsequent metastatic ability in human osteosarcomas.
    Yang SF; Lee WJ; Tan P; Tang CH; Hsiao M; Hsieh FK; Chien MH
    Oncotarget; 2015 Feb; 6(5):2736-53. PubMed ID: 25605016
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fas-negative osteosarcoma tumor cells are selected during metastasis to the lungs: the role of the Fas pathway in the metastatic process of osteosarcoma.
    Koshkina NV; Khanna C; Mendoza A; Guan H; DeLauter L; Kleinerman ES
    Mol Cancer Res; 2007 Oct; 5(10):991-9. PubMed ID: 17951400
    [TBL] [Abstract][Full Text] [Related]  

  • 17. miR-20a regulates expression of the iron exporter ferroportin in lung cancer.
    Babu KR; Muckenthaler MU
    J Mol Med (Berl); 2016 Mar; 94(3):347-59. PubMed ID: 26560875
    [TBL] [Abstract][Full Text] [Related]  

  • 18. miR-186-5p Functions as a Tumor Suppressor in Human Osteosarcoma by Targeting FOXK1.
    Zhang Z; Zhang W; Mao J; Xu Z; Fan M
    Cell Physiol Biochem; 2019; 52(3):553-564. PubMed ID: 30897321
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MicroRNA-183 promotes migration and invasion of CD133(+)/CD326(+) lung adenocarcinoma initiating cells via PTPN4 inhibition.
    Zhu C; Deng X; Wu J; Zhang J; Yang H; Fu S; Zhang Y; Han Y; Zou Y; Chen Z; Lin S
    Tumour Biol; 2016 Aug; 37(8):11289-97. PubMed ID: 26951513
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Down-regulation of miR-183 promotes migration and invasion of osteosarcoma by targeting Ezrin.
    Zhu J; Feng Y; Ke Z; Yang Z; Zhou J; Huang X; Wang L
    Am J Pathol; 2012 Jun; 180(6):2440-51. PubMed ID: 22525461
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.